Autoantibody against transient receptor potential M1 cation channels of retinal on bipolar cells in paraneoplastic vitelliform retinopathy

BMC Ophthalmology

Volumn 12, Issue 1, 2012, Pages

  Wang, Yujuan ^a,b   Abu Asab, Mones S ^a   Li, Wei ^a   Aronow, Mary E ^c   Singh, Arun D ^c   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Autoantibody; Autoimmune retinopathy; Bipolar cell; Melanoma associated retinopathy; Paraneoplastic vitelliform retinopathy; Transient receptor potential channel

Indexed keywords

AUTOANTIBODY; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM1 PROTEIN, HUMAN;

AGED; ARTICLE; CASE REPORT; HUMAN; IMMUNOLOGY; MALE; METABOLISM; OCULAR PARANEOPLASTIC SYNDROME; PATHOLOGY; RETINA BIPOLAR GANGLION CELL;

AGED, 80 AND OVER; AUTOANTIBODIES; HUMANS; MALE; PARANEOPLASTIC SYNDROMES, OCULAR; RETINAL BIPOLAR CELLS; TRPM CATION CHANNELS;

EID: 84868661532     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-12-56     Document Type: Article

References (39)

1. Autoimmune retinopathy: a review and summary. Heckenlively JR, Ferreyra HA, Semin Immunopathol 2008 30 2 127 134 10.1007/s00281-008-0114-7 18408929
2. Paraneoplastic syndromes in neuro-ophthalmology. Alabduljalil T, Behbehani R, Curr Opin Ophthalmol 2007 18 6 463 469 10.1097/ICU.0b013e3282f0b497 18162997 (Pubitemid 351339399)
3. Establishment of a novel small cell lung carcinoma cell line with specific recoverin expression from a patient with cancer-associated retinopathy. Kobayashi M, Ikezoe T, Uemura Y, Takeuchi T, Ueno H, Ohtsuki Y, Taguchi H, Lung Cancer 2007 56 3 319 326 10.1016/j.lungcan.2007.01.030 17374419 (Pubitemid 46679088)
4. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome. Khan N, Huang JJ, Foster CS, Semin Ophthalmol 2006 21 3 135 141 10.1080/08820530500350662 16912011 (Pubitemid 44266787)
5. Paraneoplastic neurological syndromes. Honnorat J, Antoine JC, Orphanet J Rare Dis 2007 2 22 10.1186/1750-1172-2-22 17480225
6. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. Keltner JL, Thirkill CE, Yip PT, J Neuroophthalmol 2001 21 3 173 187 10.1097/00041327-200109000-00004 11725182 (Pubitemid 33028979)
7. Melanoma-associated retinopathy and recurrent exudative retinal detachments in a patient with choroidal melanoma. Zacks DN, Pinnolis MK, Berson EL, Gragoudas ES, Am J Ophthalmol 2001 132 4 578 581 10.1016/S0002-9394(01) 01086-8 11589887 (Pubitemid 32904588)
8. Paraneoplastic vitelliform retinopathy associated with metastatic choroidal melanoma. Nieuwendijk TJ, Hooymans JM, Eye (Lond) 2007 21 11 1436 1437 10.1038/sj.eye.6702949 (Pubitemid 350066485)
9. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Lu Y, Jia L, He S, Hurley MC, Leys MJ, Jayasundera T, Heckenlively JR, Arch Ophthalmol 2009 127 12 1572 1580 10.1001/archophthalmol.2009.311 20008709
10. Paraneoplastic vitelliform retinopathy associated with cutaneous or uveal melanoma and metastases. Sotodeh M, Paridaens D, Keunen J, van Schooneveld M, Adamus G, Baarsma S, Klin Monbl Augenheilkd 2005 222 11 910 914 10.1055/s-2005-858840 16308825 (Pubitemid 41806695)
11. Acute exudative polymorphous paraneoplastic vitelliform maculopathy in a patient with carcinoma, not melanoma. Grunwald L, Kligman BE, Shields CL, Arch Ophthalmol 2011 129 8 1104 1106 10.1001/archophthalmol.2011.215 21825203
12. Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: a new hypothesis about disease pathogenesis. Koreen L, He SX, Johnson MW, Hackel RE, Khan NW, Heckenlively JR, Arch Ophthalmol 2011 129 1 23 29 10.1001/archophthalmol.2010.316 21220625
13. Paraneoplastic retinopathy with multiple detachments of the neurosensory retina and autoantibodies against interphotoreceptor retinoid binding protein (IRBP) in cutaneous melanoma. Bianciotto C, Shields CL, Thirkill CE, Materin MA, Shields JA, Br J Ophthalmol 2010 94 12 1684 1685 1696 10.1136/bjo.2008.151480 19286685
14. Autoantibodies against bestrophin in a patient with vitelliform paraneoplastic retinopathy and a metastatic choroidal malignant melanoma. Eksandh L, Adamus G, Mosgrove L, Andreasson S, Arch Ophthalmol 2008 126 3 432 435 10.1001/archopht.126.3.432 18332332 (Pubitemid 351398477)
15. Bilateral multifocal chorioretinopathy in a woman with cutaneous malignant melanoma. Palmowski AM, Haus AH, Pfohler C, Reinhold U, Allgayer R, Tilgen W, Ruprecht KW, Thirkill CE, Arch Ophthalmol 2002 120 12 1756 1761 12470158 (Pubitemid 36401818)
16. Paraneoplastic Vitelliform Retinopathy: Clinicopathologic Correlation and Review of the Literature. Aronow ME, Adamus G, Abu-Asab M, Wang Y, Chan CC, Singh AD, Surv Ophthalmol 2012 57 6 558 564 10.1016/j.survophthal.2012.02.004 22784677
17. TRPM1 (Melastatin-1/MLSN1) mRNA expression in Spitz nevi and nodular melanomas. Erickson LA, Letts GA, Shah SM, Shackelton JB, Duncan LM, Mod Pathol 2009 22 7 969 976 10.1038/modpathol.2009.56 19396153
18. Melastatin expression and prognosis in cutaneous malignant melanoma. Duncan LM, Deeds J, Cronin FE, Donovan M, Sober AJ, Kauffman M, McCarthy JJ, J Clin Oncol 2001 19 2 568 576 11208852 (Pubitemid 32112872)
19. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Miller AJ, Du J, Rowan S, Hershey CL, Widlund HR, Fisher DE, Cancer Res 2004 64 2 509 516 10.1158/0008-5472.CAN- 03-2440 14744763 (Pubitemid 38120889)
20. Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus). Bellone RR, Brooks SA, Sandmeyer L, Murphy BA, Forsyth G, Archer S, Bailey E, Grahn B, Genetics 2008 179 4 1861 1870 10.1534/genetics.108.088807 18660533
21. Identification of molecular markers of bipolar cells in the murine retina. Kim DS, Ross SE, Trimarchi JM, Aach J, Greenberg ME, Cepko CL, J Comp Neurol 2008 507 5 1795 1810 10.1002/cne.21639 18260140 (Pubitemid 351468224)
22. TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Morgans CW, Zhang J, Jeffrey BG, Nelson SM, Burke NS, Duvoisin RM, Brown RL, Proc Natl Acad Sci USA 2009 106 45 19174 19178 10.1073/pnas.0908711106 19861548
23. Ultrastructural localization and expression of TRPM1 in the human retina. Klooster J, Blokker J, Ten Brink JB, Unmehopa U, Fluiter K, Bergen AA, Kamermans M, Invest Ophthalmol Vis Sci 2011 52 11 8356 8362 10.1167/iovs.11-7575 21896854
24. TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Koike C, Obara T, Uriu Y, Numata T, Sanuki R, Miyata K, Koyasu T, Ueno S, Funabiki K, Tani A, Ueda H, Kondo M, Mori Y, Tachibana M, Furukawa T, Proc Natl Acad Sci USA 2010 107 1 332 337 10.1073/pnas.0912730107 19966281
25. TRPM1: a vertebrate TRP channel responsible for retinal ON bipolar function. Koike C, Numata T, Ueda H, Mori Y, Furukawa T, Cell Calcium 2010 48 2-3 95 101 20846719
26. TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Audo I, Kohl S, Leroy BP, Munier FL, Guillonneau X, Mohand-Said S, Bujakowska K, Nandrot EF, Lorenz B, Preising M, Kellner U, Renner AB, Bernd A, Antonio A, Moskova-Doumanova V, Lancelot ME, Poloschek CM, Drumare I, Defoort-Dhellemmes S, Wissinger B, Leveillard T, Hamel CP, Schorderet DF, De Baere E, Berger W, Jacobson SG, Zrenner E, Sahel JA, Bhattacharya SS, Zeitz C, Am J Hum Genet 2009 85 5 720 729 10.1016/j.ajhg.2009.10.013 19896113
27. Mutations in TRPM1 are a common cause of complete congenital stationary night blindness. van Genderen MM, Bijveld MM, Claassen YB, Florijn RJ, Pearring JN, Meire FM, McCall MA, Riemslag FC, Gregg RG, Bergen AA, Kamermans M, Am J Hum Genet 2009 85 5 730 736 10.1016/j.ajhg.2009.10.012 19896109
28. Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans. Li Z, Sergouniotis PI, Michaelides M, Mackay DS, Wright GA, Devery S, Moore AT, Holder GE, Robson AG, Webster AR, Am J Hum Genet 2009 85 5 711 719 10.1016/j.ajhg.2009.10.003 19878917
29. Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells. Dhingra A, Fina ME, Neinstein A, Ramsey DJ, Xu Y, Fishman GA, Alexander KR, Qian H, Peachey NS, Gregg RG, Vardi N, J Neurosci 2011 31 11 3962 3967 10.1523/JNEUROSCI.6007-10.2011 21411639
30. Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. Kondo M, Sanuki R, Ueno S, Nishizawa Y, Hashimoto N, Ohguro H, Yamamoto S, Machida S, Terasaki H, Adamus G, Furukawa T, PLoS One 2011 6 5 19911 10.1371/journal.pone. 0019911 21611200
31. Developmentally regulated postsynaptic localization of a metabotropic glutamate receptor in rat rod bipolar cells. Nomura A, Shigemoto R, Nakamura Y, Okamoto N, Mizuno N, Nakanishi S, Cell 1994 77 3 361 369 10.1016/0092-8674(94) 90151-1 8181056 (Pubitemid 24145197)
32. Differential expression of ionotropic glutamate receptor subunits in the outer retina. Morigiwa K, Vardi N, J Comp Neurol 1999 405 2 173 184 10.1002/(SICI)1096-9861(19990308)405:2<173::AID-CNE3>3.0.CO;2-L 10023808 (Pubitemid 29066231)
33. TRPM1: the endpoint of the mGluR6 signal transduction cascade in retinal ON-bipolar cells. Morgans CW, Brown RL, Duvoisin RM, Bioessays 2010 32 7 609 614 10.1002/bies.200900198 20544736
34. A comparison of immunocytochemical markers to identify bipolar cell types in human and monkey retina. Haverkamp S, Haeseleer F, Hendrickson A, Vis Neurosci 2003 20 6 589 600 10.1017/S0952523803206015 15088712 (Pubitemid 38736052)
35. Amacrine cell gene expression and survival signaling: differences from neighboring retinal ganglion cells. Kunzevitzky NJ, Almeida MV, Goldberg JL, Invest Ophthalmol Vis Sci 2010 51 7 3800 3812 10.1167/iovs.09-4540 20445109
36. Disabled-1 alternative splicing in human fetal retina and neural tumors. Katyal S, Glubrecht DD, Li L, Gao Z, Godbout R, PLoS One 2011 6 12 28579 10.1371/journal.pone.0028579 22163036
37. Loss of LMO4 in the retina leads to reduction of GABAergic amacrine cells and functional deficits. Duquette PM, Zhou X, Yap NL, MacLaren EJ, Lu JJ, Wallace VA, Chen HH, PLoS One 2010 5 10 13232 10.1371/journal.pone.0013232 20949055
38. Localization of L-glutamic acid decarboxylase mRNA in cat retinal horizontal cells by in situ hybridization. Sarthy PV, Fu M, J Comp Neurol 1989 288 4 593 600 10.1002/cne.902880406 2808751 (Pubitemid 19271009)
39. GFAP-driven GFP expression in activated mouse Muller glial cells aligning retinal blood vessels following intravitreal injection of AAV2/6 vectors. Aartsen WM, van Cleef KW, Pellissier LP, Hoek RM, Vos RM, Blits B, Ehlert EM, Balaggan KS, Ali RR, Verhaagen J, Wijnholds J, PLoS One 2010 5 8 12387 10.1371/journal.pone.0012387 20808778